BioSpace News Archive

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, is pleased to formally announce the appointment of Christine Vannais as Chief Operating Officer (COO) of its North Carolina site, effective April 1, 2020.

H4D, a leading global telemedicine company, is joining the international effort to fight the global coronavirus pandemic. H4D is providing hospitals with a fast, efficient and reliable solution to improve patient flow management in the emergency department

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on trends driving the pharma industry.

Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement using the TSolution One® Total Knee Application.

The UNC Medical Center McLendon Clinical Laboratories in Chapel Hill have developed a diagnostic test for coronavirus disease 2019 based on a World Health Organization assay. The UNC test is now in use at the medical center in Chapel Hill, NC.

All CEOs, founders and owners of independent marketing service agencies are invited to join in taking the COVID CEO Pledge.

Meritech is taking additional safety precautions to protect the health of their employees, customers, and community and to maintain the same level of quality human hygiene services they have always delivered.

Company in process of submitting New Drug Application for Neutrolin® for prevention of catheter-related blood stream infections via a rolling review granted by FDA

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, announced that Mark Enyedy has been appointed to its Board of Directors, effective as of March 17, 2020.

BioSpecifics Technologies Corp. announced its financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.